Literature DB >> 34296034

Giant cell tumor of the thoracic spine causing acute paraplegia-a case report.

Christopher Lucasti1, Dil Patel1, Bradley Hawayek2, Mark Maraschiello2, Joseph Kowalski1.   

Abstract

Giant cell tumors (GCT) are rare and account for approximately 5% of all primary bone tumors. GCTs in the spine make up less than 10% of all GCTs, and less than 5% of all primary spinal tumors. Less than 10% of spinal GCTs occur above the sacrum and cases involving the thoracic spine are seldom reported in the literature. In our case the patient presented with acute paraplegia of bilateral lower extremities after being seen in the emergency department a day earlier. An MRI and CT scan demonstrated near complete destruction of T8 vertebral body with a possible pathologic lesion and fracture associated with dorsal and ventral spinal cord compression and significant signal change within the spinal cord. She underwent T7-T9 laminectomy with excisional biopsy and was subsequently diagnosed with a primary GCT of the thoracic spine. She was definitively treated with resection and T4-12 fusion and 120 mg of denosumab. At four years post follow-up there has been no recurrence of the tumor to date. This is a more acute presentation than has previously been reported. Patients with GCT of the spine typically present with pain and may have further progression to neurologic deficit. This patient's rapid onset of paraplegia is more acute than has been previously reported in the literature. The authors believe that prompt surgical excision and treatment with denosumab can completely resolve GCT of the thoracic spine. 2021 Journal of Spine Surgery. All rights reserved.

Entities:  

Keywords:  Giant cell tumor (GCT); case report; denosumab; fusion; spine

Year:  2021        PMID: 34296034      PMCID: PMC8261563          DOI: 10.21037/jss-20-652

Source DB:  PubMed          Journal:  J Spine Surg        ISSN: 2414-4630


  17 in total

1.  Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

Authors:  Sant Chawla; Jean-Yves Blay; Piotr Rutkowski; Axel Le Cesne; Peter Reichardt; Hans Gelderblom; Robert J Grimer; Edwin Choy; Keith Skubitz; Leanne Seeger; Scott M Schuetze; Robert Henshaw; Tian Dai; Danielle Jandial; Emanuela Palmerini
Journal:  Lancet Oncol       Date:  2019-11-06       Impact factor: 41.316

Review 2.  Giant Cell Tumor of the Mobile Spine Occurring in Pregnancy: A Case Report and Literature Review.

Authors:  Kai Zheng; Ming Xu; Bing Wang; Xiu-Chun Yu; Yong-Cheng Hu
Journal:  Orthop Surg       Date:  2017-05-26       Impact factor: 2.071

3.  Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.

Authors:  Wei Xu; Xiang Li; Wending Huang; Yu Wang; Shuai Han; Su Chen; Leqin Xu; Xinghai Yang; Tielong Liu; Jianru Xiao
Journal:  Ann Surg Oncol       Date:  2012-10-25       Impact factor: 5.344

4.  Spinal Cord Injury due to the Giant Cell Tumor of the Second Thoracic Vertebra: A Case Report.

Authors:  Hee-Sang Kim; Jong Eon Lee; Sang Soo Jung; Jinmann Chon; Dong Hwan Yoon; Yong-Koo Park; Eun Hye Cho
Journal:  Ann Rehabil Med       Date:  2013-04-30

5.  Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.

Authors:  Sant Chawla; Robert Henshaw; Leanne Seeger; Edwin Choy; Jean-Yves Blay; Stefano Ferrari; Judith Kroep; Robert Grimer; Peter Reichardt; Piotr Rutkowski; Scott Schuetze; Keith Skubitz; Arthur Staddon; David Thomas; Yi Qian; Ira Jacobs
Journal:  Lancet Oncol       Date:  2013-07-16       Impact factor: 41.316

6.  Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.

Authors:  Julia Rockberg; Bruce A Bach; Justyna Amelio; Rohini K Hernandez; Patrik Sobocki; Jacob Engellau; Henrik C F Bauer; Alexander Liede
Journal:  J Bone Joint Surg Am       Date:  2015-11-04       Impact factor: 5.284

7.  Giant cell tumors of the axial skeleton.

Authors:  Maurice Balke; Marcel P Henrichs; Georg Gosheger; Helmut Ahrens; Arne Streitbuerger; Michael Koehler; Viola Bullmann; Jendrik Hardes
Journal:  Sarcoma       Date:  2012-02-08

8.  A case of thoracic giant cell tumor of bone and discussion of radiological features and current management practices.

Authors:  Deirdre Kelly; Sarah Mc Erlean; Danielle Byrne; Peter Mac Mahon; John Mc Caffrey
Journal:  Radiol Case Rep       Date:  2016-05-25

9.  Total en bloc spondylectomy of the eleventh thoracic vertebra following denosumab therapy for the treatment of a giant cell tumor.

Authors:  Gen Inoue; Takayuki Imura; Masayuki Miyagi; Wataru Saito; Ryo Tazawa; Toshiyuki Nakazawa; Masashi Takaso
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

10.  Primary malignancy in giant cell tumor of thoracic vertebrae: A case report.

Authors:  Hong Yu; Ruiqing Shi; Zhi-Gang Peng; Bao-Hai Yu; Jian-Ling Cui
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more
  1 in total

1.  A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences.

Authors:  Alessandro De Vita; Silvia Vanni; Giacomo Miserocchi; Valentina Fausti; Federica Pieri; Chiara Spadazzi; Claudia Cocchi; Chiara Liverani; Chiara Calabrese; Roberto Casadei; Federica Recine; Lorena Gurrieri; Alberto Bongiovanni; Toni Ibrahim; Laura Mercatali
Journal:  Biomedicines       Date:  2022-02-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.